Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
about
Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolismGlucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth.The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status.2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of t
P2860
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@ast
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@en
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@nl
type
label
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@ast
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@en
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@nl
prefLabel
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@ast
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@en
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@nl
P2860
P3181
P356
P1476
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
@en
P2093
Natalie J Serkova
S Gail Eckhardt
P2860
P3181
P356
10.3389/FONC.2016.00152
P407
P577
2016-01-01T00:00:00Z